GT200600272A - NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS - Google Patents

NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS

Info

Publication number
GT200600272A
GT200600272A GT200600272A GT200600272A GT200600272A GT 200600272 A GT200600272 A GT 200600272A GT 200600272 A GT200600272 A GT 200600272A GT 200600272 A GT200600272 A GT 200600272A GT 200600272 A GT200600272 A GT 200600272A
Authority
GT
Guatemala
Prior art keywords
progesterone receptors
steroid modulators
steroid
modulators
progesterone
Prior art date
Application number
GT200600272A
Other languages
Spanish (es)
Inventor
Ulrich Bothe
Ulrike Fuhrmann
Carsten Moller
Norbert Schmees
Anja Schmidt
Wolfgang Schwede
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600272A publication Critical patent/GT200600272A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A MODULADORES NO ESTEROIDEOS DE RECEPTORES DE PROGESTERONA, A SU USO PARA LA PREPARACIÓN DE MEDICAMENTOS Y A COMPOSICIONES FARMACÉUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y POR LO ANTERIOR SON DE UTILIDAD EN PATOLOGÍAS GINECOLÓGICAS TALES COMO ENDOMETRIOSIS, DISMENORREA.THE PRESENT INVENTION REFERS TO NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS, TO ITS USE FOR THE PREPARATION OF MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEREFORE THEY ARE USEFUL IN TALINOMETRIC ASSOCIATE DISEASE.

GT200600272A 2005-06-24 2006-06-26 NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS GT200600272A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (en) 2005-06-24 2005-06-24 Nonsteroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
GT200600272A true GT200600272A (en) 2007-08-20

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600272A GT200600272A (en) 2005-06-24 2006-06-26 NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS

Country Status (22)

Country Link
EP (1) EP1899315A1 (en)
JP (1) JP2008543911A (en)
KR (1) KR20080018275A (en)
CN (1) CN101248056A (en)
AR (1) AR057409A1 (en)
AU (1) AU2006261049A1 (en)
BR (1) BRPI0612305A2 (en)
CA (1) CA2611900A1 (en)
CR (1) CR9595A (en)
DE (1) DE102005030294A1 (en)
DO (1) DOP2006000150A (en)
EA (1) EA200702604A1 (en)
EC (1) ECSP078043A (en)
GT (1) GT200600272A (en)
IL (1) IL188022A0 (en)
MX (1) MX2008000070A (en)
NO (1) NO20080441L (en)
PE (1) PE20070170A1 (en)
TW (1) TW200738665A (en)
UY (1) UY29626A1 (en)
WO (1) WO2006136462A1 (en)
ZA (1) ZA200800689B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (en) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
DE102007032800A1 (en) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
DE102007058747A1 (en) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nonsteroidal progesterone receptor modulators
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US10328022B2 (en) 2012-05-31 2019-06-25 Repros Therapeutics Inc. Formulations and methods for vaginal delivery of antiprogestins
WO2014070517A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (en) * 1997-05-30 1998-12-10 Schering Ag Nonsteroidal progestogens
CN1353717A (en) * 1999-05-04 2002-06-12 莱加制药公司 Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
AU2003202216A1 (en) * 2002-01-14 2003-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1482925B1 (en) * 2002-03-11 2007-01-17 Schering AG 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
DE10346939A1 (en) * 2003-10-06 2005-05-19 Schering Ag New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases

Also Published As

Publication number Publication date
AU2006261049A1 (en) 2006-12-28
EP1899315A1 (en) 2008-03-19
DE102005030294A1 (en) 2007-01-04
BRPI0612305A2 (en) 2010-11-03
PE20070170A1 (en) 2007-03-02
DOP2006000150A (en) 2006-12-31
ECSP078043A (en) 2008-01-23
NO20080441L (en) 2008-03-07
AR057409A1 (en) 2007-12-05
UY29626A1 (en) 2007-01-31
JP2008543911A (en) 2008-12-04
MX2008000070A (en) 2008-03-19
KR20080018275A (en) 2008-02-27
TW200738665A (en) 2007-10-16
ZA200800689B (en) 2009-07-29
IL188022A0 (en) 2008-03-20
CN101248056A (en) 2008-08-20
WO2006136462A1 (en) 2006-12-28
CA2611900A1 (en) 2006-12-28
CR9595A (en) 2008-05-05
EA200702604A1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
HN2005000795A (en) PYRIMIDINS AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEPTOR
HN2011003195A (en) GPR MODULAR 119
UY30573A1 (en) N- (1-HETARIL-PIPERIDIN-4-IL) - (HET) ARILAMIDS AS MODULATORS OF THE EP2 RECEIVER
ECSP077316A (en) Substituted bicyclic imidazo-3-yl-amine compounds
GT200600144A (en) 1H-QUINAZOLIN-2,4-DIONAS
UY30572A1 (en) N- (1-FTALAZIN-1-IL-PIPERIDIN-4-IL) -AMIDAS AS MODULATORS OF THE EP2 RECEIVER
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
CR9786A (en) BENCIMIDAZOL-THIOPHEN COMPOUNDS
GT200600272A (en) NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
AR057239A1 (en) IMMUNOGLOBULINS
CR10497A (en) USEFUL PIPERAZINYL DERIVATIVES IN THE TREATMENT OF DISEASES MEDIATED BY THE GPR38 RECEIVER
UY31922A (en) COMPOUNDS
UY33470A (en) DERIVATIVES OF 6,7-DIHIDRO-5H-BENZO [7] ANNULMENTS, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF MEDICINES
CR10060A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
UY31403A1 (en) "NOVEDOUS DERIVATIVES OF ({((3-Methylphenyl) -2H-TETRAZOL-5-IL) -ETOXI} -4H-1,2,4-TRIAZOL-3-IL), PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND MEDICAL USE OF THE SAME" .
CO6351723A2 (en) DERIVATIVES OF PIRAZOLO- [5,1-B] -OXAZOL AS AN ANTIGONIST OF CRF1
EA201101118A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING 2-OXO-1-PYRROLIDINE DERIVATIVES
AR059741A1 (en) LIQUID AND SEMISOLID PHARMACEUTICAL FORMULATIONS AND PROCEDURES
PA8795901A1 (en) NEW NOVEDOUS COMPOUNDS AS ANTAGONISTS OF MUSCARINIC RECEPTORS
UY29625A1 (en) USE OF NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS
BR112013012719A2 (en) "compounds as receptor modulators of therapeutic utility".
GT200600271A (en) NON-ESTERID MODULATORS OF PROGESTERONE RECEPTORS
CO6541615A2 (en) BICYCLIC TIAZOLS AS ALLERGIC MODULATORS OF MGLUR5 RECEPTORS
BR112012029565A2 (en) controlled release pharmaceutical composition of losartan.
CL2007002788A1 (en) A COMPOUND DERIVED FROM (CIS) -8-FLUORODIBENZO [B, F] PIRIDO [1,2-D] OXAZEPIN-1-AMINA, MODULATOR OF PROGESTERONE RECEPTORS; PHARMACEUTICAL COMPOSITION; AND USE AS AN CONTRACEPTIVE, FOR HORMONAL REPLACEMENT THERAPY OR FOR THE TREATMENT OF A REAR